Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

AI-Assisted Interpretation of Ultra-Widefield Retinal Images

10. Juni 2026 aktualisiert von: XiujuChen, Xiamen Ophthalmology Center Affiliated to Xiamen University

Prospective Multi-Center Evaluation of AI-Assisted Interpretation of Ultra-Widefield Retinal Images in a Multi-Reader Crossover Study

The goal of this prospective observational study is to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

The main questions it aims to answer are:

whether AI assistance improves the diagnostic performance of ophthalmologists in detecting retinal findings on UWF retinal images; whether AI assistance improves sensitivity, specificity, and inter-reader agreement across clinicians with different levels of experience.

Approximately 600 UWF retinal images prospectively collected from multiple ophthalmic centers in China will be included. Images will be independently annotated by expert retinal specialists to establish reference labels for retinal finding categories.

Four ophthalmologists with different levels of clinical experience, including one senior retinal specialist and three junior ophthalmologists, will participate in a crossover multi-reader study.

For each clinician, the dataset will be randomly divided into two equal subsets. During the first reading session, clinicians will evaluate one subset without AI assistance and the other subset with AI assistance. After a washout interval of at least two weeks, the reading conditions will be reversed in a second reading session with independently randomized image order.

Under the AI-assisted condition, clinicians will be provided with category-level AI prediction probabilities for retinal findings. No localization maps, heatmaps, segmentation overlays, or automated diagnostic recommendations will be displayed. Clinicians will retain full autonomy over final decisions.

Reader performance under AI-assisted and unaided conditions will be compared using expert reference annotations as the ground truth.

Studienübersicht

Status

Abgeschlossen

Bedingungen

Detaillierte Beschreibung

This study is a prospective multi-center observational reader study designed to evaluate the impact of artificial intelligence (AI) assistance on clinician interpretation of ultra-widefield (UWF) retinal images.

Approximately 600 UWF retinal images will be prospectively collected from multiple ophthalmic centers in China. Images will be acquired using clinically routine UWF retinal imaging systems and will include a broad spectrum of retinal diseases and retinal findings encountered in real-world clinical practice.

All images will undergo independent expert annotation by retinal specialists to establish reference labels for retinal finding categories. These expert annotations will serve as the reference standard for subsequent performance evaluation.

Four ophthalmologists with different levels of clinical experience will participate in the reader study, including:

one senior retinal specialist with approximately five years of retinal clinical experience; three junior ophthalmologists with approximately two years of ophthalmology residency training.

A randomized crossover multi-reader design will be implemented to minimize recall bias and balance reading conditions.

For each clinician, the image dataset will be randomly divided into two equal subsets (subset A and subset B; approximately 300 images each).

During Round 1:

subset A will be interpreted without AI assistance; subset B will be interpreted with AI assistance.

After a washout interval of at least two weeks, the reading conditions will be reversed during Round 2:

subset A will be interpreted with AI assistance; subset B will be interpreted without AI assistance.

Image order will be independently randomized for each session and each clinician.

Under the unaided condition, clinicians will evaluate retinal images using standard clinical interpretation without AI output.

Under the AI-assisted condition, clinicians will receive category-level AI prediction probabilities for retinal finding categories. The AI output will provide probabilistic confidence scores only and will not include lesion localization maps, heatmaps, segmentation overlays, or automated binary recommendations.

Clinicians will remain blinded to the expert reference labels and to the interpretations of other readers. Final diagnostic decisions will be independently determined by each clinician.

The primary analysis will compare diagnostic performance between unaided and AI-assisted conditions, including sensitivity, specificity, area under the receiver operating characteristic curve (AUC), and inter-reader agreement.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

462

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Chongqing Municipality
      • Chongqing, Chongqing Municipality, China
        • Chongqing Huaxia Eye Hospital
    • Fujian
      • Fuzhou, Fujian, China, 361000
        • Fuzhou Eye Hospital
      • Xiamen, Fujian, China, 361000
        • Xiamen Eye Center of Xiamen University
    • Hebei
      • Hengshui, Hebei, China
        • Hengshui Tongrui Eye Hospital
    • Shandong
      • Heze, Shandong, China
        • Heze Huaxia Eye Hospital

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

  • Erwachsene
  • Älterer Erwachsener

Akzeptiert gesunde Freiwillige

Ja

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Participants undergoing clinically indicated ultra-widefield retinal imaging at participating ophthalmic centers in China, including individuals with diverse retinal diseases and retinal findings encountered in real-world clinical practice.

Beschreibung

Inclusion Criteria:

  • Participants undergoing ultra-widefield retinal imaging at participating ophthalmic centers;

Exclusion Criteria:

  • Poor-quality or ungradable retinal images;

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
AI-Assisted Interpretation
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Clinicians interpret ultra-widefield retinal images with access to AI-generated category-level prediction probabilities for retinal findings.
Unaided Interpretation
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.
Clinicians interpret ultra-widefield retinal images without AI assistance using routine retinal image interpretation alone.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Sensitivity for retinal finding detection
Zeitfenster: through study completion, an average of 2 months
Sensitivity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions using expert annotations as the reference standard.
through study completion, an average of 2 months
Specificity for retinal finding detection
Zeitfenster: through study completion, an average of 2 months
Specificity of clinicians in detecting retinal finding categories under AI-assisted and unaided conditions.
through study completion, an average of 2 months

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Area under the receiver operating characteristic curve (AUC)
Zeitfenster: through study completion, an average of 2 months
The AUC quantifies the overall ability to correctly distinguish the presence versus absence of predefined retinal findings on ultra-widefield retinal images. AUC values range from 0.5 (no discriminative ability) to 1.0 (perfect discrimination). Clinician interpretations will be compared with an expert-adjudicated reference standard under AI-assisted and unaided conditions.
through study completion, an average of 2 months
Inter-reader agreement
Zeitfenster: At study completion (up to 3 months)
Agreement among participating clinicians in classifying predefined retinal findings on ultra-widefield retinal images. Agreement will be quantified using Cohen's kappa coefficient (for pairwise comparisons) or Fleiss' kappa coefficient (for multiple readers). Kappa values range from 0 (no agreement beyond chance) to 1 (perfect agreement).
At study completion (up to 3 months)
Diagnostic performance improvement among junior ophthalmologists
Zeitfenster: At study completion (up to 3 months)
Improvement in diagnostic performance of junior ophthalmologists when interpreting ultra-widefield retinal images with AI assistance compared with unaided interpretation, measured by changes in sensitivity, specificity, accuracy, and AUC using the expert-adjudicated reference standard.
At study completion (up to 3 months)

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Xiuju Chen, Xiamen Eye Center of Xiamen University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. Januar 2026

Primärer Abschluss (Tatsächlich)

1. Februar 2026

Studienabschluss (Tatsächlich)

10. Februar 2026

Studienanmeldedaten

Zuerst eingereicht

5. Juni 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

10. Juni 2026

Zuerst gepostet (Tatsächlich)

16. Juni 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

16. Juni 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

10. Juni 2026

Zuletzt verifiziert

1. Juni 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Zusätzliche relevante MeSH-Bedingungen

Andere Studien-ID-Nummern

  • XMYKZX-KY-2026-008

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Beschreibung des IPD-Plans

De-identified individual participant data underlying the results reported in this study, including retinal imaging data and associated annotations, may be made available upon reasonable request to the corresponding investigator following publication, subject to institutional ethics approval, data-sharing agreements, and applicable data governance and privacy regulations.

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren